Inventor · disambiguated record
William B. Weglicki
Also filed as: WEGLICKI WILLIAM B
8 granted patents·56 citations·filing 1996–2016
84Inventor score
Top patents by PatentIndex Score
8 records- 0185US9687493B2Use of NK-1 receptor antagonists for treating hypomagnesemia, neurogenic inflammation, and cardiac dysfunction associated with EGFR-blocking drugsUNIV GEORGE WASHINGTON·Filed 2016·Granted Jun 27, 2017·4 cites·18 claims
- 0271US6100297AIntravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distributionUNIV GEORGE WASHINGTON·Filed 1999·Granted Aug 8, 2000·28 cites·8 claims
- 0363US9474761B2Use of NK-1 receptor antagonists for treating hypomagnesemia, neurogenic inflammation, and cardiac dysfunction associated with EGFR-blocking drugsWEGLICKI WILLIAM B·Filed 2015·Granted Oct 25, 2016·1 cites·25 claims
- 0451US5854287AD-Propranolol metabolites useful for antioxidant activitiesFiled 1997·Granted Dec 29, 1998·15 cites·9 claims
- 0542US5843996AIntravenous magnesium gluconate for treatment of conditions caused by excessive oxidative stress due to free radical distributionFiled 1997·Granted Dec 1, 1998·5 cites·7 claims
- 0633US6121328ARacemic propranololUNIV GEORGE WASHINGTON·Filed 1998·Granted Sep 19, 2000·2 cites·5 claims
- 0730US5919828ARacemic propranololFiled 1996·Granted Jul 6, 1999·1 cites·1 claims
- 0818US5776985AFluorinated propranolol and related methodsUNIV GEORGE WASHINGTON·Filed 1996·Granted Jul 7, 1998·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when William B. Weglicki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →